Back to Trades
Grant4
Moderna, Inc.
MRNA
Total Value
$228.8K
Company Information
- Company Name
- Moderna, Inc.
- Ticker Symbol
- MRNA
- CIK
- 0001682852
Insider Information
- Name
- Bancel Stephane
- Role
- Chief Executive Officer, Director
- Location
- CAMBRIDGE, MA
DirectorOfficer
Filing Details
- Filing Date
- Feb 13, 2026
- Transaction Date
- Feb 11, 2026
- Accession Number
- 0001682852-26-000017
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 11, 2026 | Common Stock | 11,271 | — | Grant/Award | — |
| Feb 11, 2026 | Common Stock | 5,450 | $41.99 | Tax Withholding | $228.8K |
Footnotes
- (F1)The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on February 28, 2023 (the "2023 PSUs").
- (F2)Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the 2023 PSUs.
- (F3)These shares are owned directly by Boston Biotech Ventures. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
- (F4)These shares are owned directly by OCHA LLC ("OCHA"). The reporting person is the majority equity unit holder and the sole managing member of OCHA. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.